Harrow, Inc.
HROW
#6082
Rank
HK$8.63 B
Marketcap
HK$230.39
Share price
-3.80%
Change (1 day)
-27.03%
Change (1 year)

Earnings for Harrow, Inc. (HROW)

Earnings in 2026 (TTM): -HK$83.23 Million

According to Harrow, Inc.'s latest financial reports the company's current earnings are HK$0.27 Billion. In 2025 the company made an earning of HK$0.17 Billion, an increase over its 2024 earnings that were of HK$42.89 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Harrow, Inc. from 2007 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -HK$83.23 Million-146.49%
2025 HK$0.17 B317.34%
2024 HK$42.89 M-329.09%
2023 -HK$18.73 Million-224.34%
2022 HK$15.05 M3.01%
2021 HK$14.61 M149.06%
2020 HK$5.86 M434.29%
2019 HK$1.09 M-102.68%
2018 -HK$40.94 Million-57.11%
2017 -HK$95.45 Million-21.93%
2016 -HK$0.13 Billion5.11%
2015 -HK$0.12 Billion46.16%
2014 -HK$79.58 Million32.68%
2013 -HK$59.98 Million42.63%
2012 -HK$42.06 Million
2010 -HK$19.43 Million-45.76%
2009 -HK$35.82 Million21.83%
2008 -HK$29.4 Million-491.97%
2007 HK$7.5 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-HK$0.63 Billion 664.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-HK$0.15 Billion 73.81%๐Ÿ‡บ๐Ÿ‡ธ USA